tldrdailynews.com logo

Pfizer Raises 2025 Profit Outlook Amid Cost Savings and Tariff Challenges

1 min read
Source: Seeking Alpha
Pfizer Raises 2025 Profit Outlook Amid Cost Savings and Tariff Challenges
Photo: Seeking Alpha
TL;DR

Pfizer has raised its 2025 EPS guidance to $2.90–$3.10 and aims for margin expansion through $7.7 billion in cost savings by 2027, with CEO Albert Bourla highlighting progress in R&D, portfolio expansion, and improved margins.

Topics:business#2025#business#cost-savings#eps-guidance#margin-expansion#pfizer
Share this article
  1. Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027  Seeking Alpha
  2. Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results  CNBC
  3. Pfizer Stock Rises as Earnings Smash Expectations. Guidance Hiked Amid Tariffs.  Barron's
  4. Why Shares of Pfizer Soared Today  Yahoo Finance
  5. Pfizer boosts profit estimate, even as the drug giant absorbs tariffs  MarketWatch

Want the full story? Read the original reporting

Read on Seeking Alpha